What are the critical protein expression changes and post-translational modifications (phosphorylation, ubiquitination, glycosylation) at the aging synapse that drive early Alzheimer disease pathophysiology? Focus on: (1) synaptic vesicle proteins and their PTM states, (2) scaffold proteins and their altered interactions, (3) receptor tyrosine kinase signaling cascades, (4) mitochondrial proteins at the synapse, and (5) proteins involved in amyloid precursor protein processing. How do these proteomic changes correlate with cognitive decline and which represent therapeutic intervention points?

I'd be happy to critically evaluate hypotheses for you, but I don't see any specific hypotheses provided in your message. Could you please share the hypotheses from the Theorist that you'd like me to analyze?

Once you provide them, I'll systematically evaluate each one by:

1. Identifying specific weaknesses - Looking for logical gaps, unsupported assumptions, overgeneralizations, or methodological flaws
2. Citing counter-evidence - Searching the literature for contradictory findings or alternative explanations
3. Proposing falsification experiments - Designing specific tests that could disprove the hypothesis
4. Providing revised confidence scores - Assessing the strength of evidence and likelihood of the hypothesis being correct

Please share the hypotheses you'd like me to evaluate, and I'll conduct a thorough critical analysis using available scientific literature and databases.

I notice that your message appears to be incomplete - you've provided the framework for hypothesis assessment but haven't included the actual hypotheses you'd like me to evaluate.

To provide you with a thorough druggability and feasibility assessment, I'll need you to share:

1. The specific hypotheses you want me to analyze
2. The target disease/condition (since you mentioned neurodegenerative diseases)
3. Any specific molecular targets or pathways mentioned in the hypotheses

Once you provide the hypotheses, I can systematically evaluate each one using the framework you've outlined:

Critical Analysis:
- Identify weaknesses and gaps
- Search for counter-evidence in the literature
- Propose falsification experiments
- Provide revised confidence scores

Druggability Assessment:
- Target tractability analysis
- Existing therapeutic approaches
- Competitive landscape review
- Development timeline and cost estimates
- Safety and regulatory considerations

Please share the hypotheses you'd like me to evaluate, and I'll conduct a comprehensive analysis using PubMed searches and gene databases to provide evidence-based assessments.

[API Error: Error code: 400 - {'message': 'tools: Input should be a valid list'}]